Patents by Inventor Alex Nivorozhkin

Alex Nivorozhkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System and method for detection of a contaminated beverage
    Patent number: 9285352
    Abstract: An apparatus may be configured to test a beverage, the apparatus may include but is not limited to, a beverage container that may be configured to hold a beverage, wherein the beverage container may include a material. An indicator may be chemically bonded to at least a portion of the material of the beverage container, wherein at least the portion of the material of the beverage container may include the indicator, wherein the indicator may be associated with at least part of a brand profile to identify a brand of the beverage, wherein the indicator may visibly react when the indicator is contacted with the beverage to show whether the beverage may be identified as the brand of the beverage, and wherein the visible reaction may be shown on at least the portion of the material of the beverage container via the indicator chemically bonded to at least the portion of the material of the beverage container.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: March 15, 2016
    Assignee: DrinkSavvy, Inc.
    Inventors: Michael T. Abramson, Alex Nivorozhkin, Nelson Landrau, John C. MacDonald, Brendan Walker
  • HSP70 fusion protein conjugates and uses thereof
    Patent number: 9217018
    Abstract: The present invention relates to novel therapies that utilize HSP70 fusion proteins for the treatment of disorders or conditions regulated by HSP70.
    Type: Grant
    Filed: December 15, 2012
    Date of Patent: December 22, 2015
    Inventors: Sergei B Onikienko, Alex Nivorozhkin, Alexander V Zemlyanoi, Mikhail Viktorovich Shorokhov, Vladimir Ivanovich Pereguda, Valery Aleksandrovich Chereshnev
  • SYSTEM AND METHOD FOR DETECTION OF A CONTAMINATED BEVERAGE
    Publication number: 20150104861
    Abstract: An apparatus may be configured to test a beverage, the apparatus may include but is not limited to, a beverage container that may be configured to hold a beverage, wherein the beverage container may include a material. An indicator may be chemically bonded to at least a portion of the material of the beverage container, wherein at least the portion of the material of the beverage container may include the indicator, wherein the indicator may be associated with at least part of a brand profile to identify a beverage brand's beverage, wherein the indicator may visibly react when the indicator is contacted with the beverage to show whether the beverage may be identified as the beverage brand's beverage, and wherein the visible reaction may be shown on at least the portion of the material of the beverage container via the indicator chemically bonded to at least the portion of the material of the beverage container.
    Type: Application
    Filed: December 17, 2014
    Publication date: April 16, 2015
    Inventors: Michael T. Abramson, Alex Nivorozhkin, Nelson Landrau, John C. MacDonald, Brendan Walker
  • NOVEL METHODS OF USE OF HSP70 FOR INCREASED PERFORMANCE OR TREATMENT OF HSP70 RELATED DISORDERS
    Publication number: 20140329764
    Abstract: The present invention relates to novel therapies that utilize exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of exogenous HSP70.
    Type: Application
    Filed: July 16, 2014
    Publication date: November 6, 2014
    Applicant: Alternative Innovative Technologies LLC
    Inventors: Sergei B. Onikienko, Alex Nivorozhkin, Alexander V. Zemlyanoi
  • HSP70 FUSION PROTEIN CONJUGATES AND USES THEREOF
    Publication number: 20130156694
    Abstract: The present invention relates to novel therapies that utilize HSP70 fusion proteins for the treatment of disorders or conditions regulated by HSP70.
    Type: Application
    Filed: December 15, 2012
    Publication date: June 20, 2013
    Applicant: ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC
    Inventors: Sergei B. Onikienko, Alex Nivorozhkin, Alexander V. Zemlyanoi, Mikhail Viktorovich Shorokhov, Vladimir Ivanovich Pereguda, Valery Aleksandrovich Chereshnev
  • DEGRADATION RESISTANT HSP70 FORMULATIONS AND USES THEREOF
    Publication number: 20130101573
    Abstract: The present invention relates to novel therapies that utilize stabilized exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of degradation resistant formulations of HSP70.
    Type: Application
    Filed: October 13, 2012
    Publication date: April 25, 2013
    Applicant: Alternative Innovative Technologies LLC
    Inventors: Sergei B. Onikienko, Alex Nivorozhkin
  • NOVEL METHODS OF USE OF HSP70 FOR INCREASED PERFORMANCE OR TREATMENT OF HSP70 RELATED DISORDERS
    Publication number: 20130090294
    Abstract: The present invention relates to novel therapies that utilize exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of exogenous HSP70.
    Type: Application
    Filed: June 28, 2012
    Publication date: April 11, 2013
    Applicant: ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC
    Inventors: Sergei B. Onikienko, Alex Nivorozhkin, Alexander V. Zemlyanoi
  • PARENTERAL FORMULATIONS OF DOPAMINE AGONISTS
    Publication number: 20100035886
    Abstract: This invention relates to stable pharmaceutical compositions for parenteral administration comprising dopamine agonists and peripheral acting agents useful for treatment of metabolic disorders or key elements thereof. The parenteral dosage forms exhibit long stable shelf life and distinct pharmacokinetics.
    Type: Application
    Filed: March 12, 2009
    Publication date: February 11, 2010
    Applicant: VeroScience, LLC
    Inventors: Anthony H. Cincotta, Alex Nivorozhkin, Nelson Landrau
  • 5-Aryltetrazole compounds and uses thereof
    Patent number: 7135491
    Abstract: The present invention relates to 5-Aryltetrazole Compounds, compositions comprising an effective amount of a a 5-Aryltetrazole Compound, and methods for treating an inflammation disease, a reperfusion disease, or hyperuricemia in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.
    Type: Grant
    Filed: January 6, 2005
    Date of Patent: November 14, 2006
    Assignee: Inotek Pharmaceuticals Corp.
    Inventors: Alex Nivorozhkin, John Van Duzer, Andrew Salzman, Garry Southan, Siya Ram, Qi Zeng, Csaba Szabo
  • Aryltetrazole compounds, and compositions thereof
    Patent number: 7087631
    Abstract: The present invention relates to 5-Aryltetrazole Compounds, compositions comprising an effective amount of a 5-Aryltetrazole Compound, and methods for treating an inflammation disease, a reperfusion disease, or hyperuricemia in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.
    Type: Grant
    Filed: July 17, 2003
    Date of Patent: August 8, 2006
    Assignee: Inotek Pharmaceuticals Corporation
    Inventors: Alex Nivorozhkin, John Van Duzer, Garry Southan, Siya Ram, Qi Zeng
  • 5-Aryltetrazole compounds, compositions thereof, and uses therefor
    Patent number: 7078423
    Abstract: The present invention relates to 5-Aryltetrazole compounds, compositions comprising a 5-Aryltetrazole compound, and methods for treating an inflammation disease, a reperfusion disease, hyperuricemia, gout, or tumor-lysis syndrome in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.
    Type: Grant
    Filed: July 18, 2002
    Date of Patent: July 18, 2006
    Assignee: Inotek Pharmaceuticals Corporation
    Inventors: Alex Nivorozhkin, John Van Duzer, Andrew Salzman, Garry Southan, Siya Ram, Qi Zeng, Csaba Szabo
  • 5-Aryltetrazoles compounds and compositions thereof
    Publication number: 20050159418
    Abstract: The present invention relates to 5-Aryltetrazole Compounds, compositions comprising an effective amount of a a 5-Aryltetrazole Compound, and methods for treating an inflammation disease, a reperfusion disease, or hyperuricemia in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.
    Type: Application
    Filed: January 6, 2005
    Publication date: July 21, 2005
    Inventors: Alex Nivorozhkin, John Van Duzer, Garry Southan, Siya Ram, Qi Zeng
  • 5-Aryltetrazole compounds and uses thereof
    Publication number: 20050159467
    Abstract: The present invention relates to 5-Aryltetrazole Compounds, compositions comprising an effective amount of a a 5-Aryltetrazole Compound, and methods for treating an inflammation disease, a reperfusion disease, or hyperuricemia in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.
    Type: Application
    Filed: January 6, 2005
    Publication date: July 21, 2005
    Inventors: Alex Nivorozhkin, John Van Duzer, Andrew Salzman, Garry Southan, Siya Ram, Qi Zeng, Csaba Szabo
  • 5-Aryltetrazole compounds, compositions thereof, and uses therefor
    Publication number: 20040116423
    Abstract: The present invention relates to 5-Aryltetrazole Compounds, compositions comprising an effective amount of a a 5-Aryltetrazole Compound, and methods for treating an inflammation disease, a reperfusion disease, or hyperuricemia in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.
    Type: Application
    Filed: July 17, 2003
    Publication date: June 17, 2004
    Inventors: Alex Nivorozhkin, John Van Duzer, Andrew Salzman, Garry Southan, Siya Ram, Qi Zeng, Csaba Szabo
  • 5-Aryltetrazole Compounds, compositions thereof, and uses therefor
    Publication number: 20040019208
    Abstract: The present invention relates to 5-Aryltetrazole compounds, compositions comprising a 5-Aryltetrazole compound, and methods for treating an inflammation disease, a reperfusion disease, hyperuricemia, gout, or tumor-lysis syndrome in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.
    Type: Application
    Filed: July 18, 2002
    Publication date: January 29, 2004
    Inventors: Alex Nivorozhkin, John Van Duzer, Andrew Salzman, Garry Southan, Siya Ram, Qi Zeng, Csaba Szabo